Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	59.72	15.38	9.63
Graham Fair Price	inf	0.00	7.96
PEG	0.00	0.00	0.00
Price/Book	inf	0.00	0.38
Price/Cash Flow	inf	0.00	-2.12
Prices/Earnings	inf	0.00	11.02
Price/Sales	inf	0.00	0.40
Price/FCF	inf	0.00	-2.12
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	-5.21	0.46	0.48
Operating Margin	-27.76	0.07	0.10
ROA	-37.04	< 0.005	< 0.005
ROE	< 0.005	< 0.005	-38.23
ROIC	0.01	0.01	-27.45
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	-0.03	-0.04	27.71
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	1.39	-0.34	-75.52
EPS QOQ	0.00	-1.00	-100.00
FCF QOQ	-2.37	0.00	inf
Revenue QOQ	-0.02	-0.09	-312.96
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	195.10	208.81	7.03
Days Sales Outstanding (DSO)	88.81	83.45	-6.04
Inventory Turnover	0.46	0.43	-6.57
Debt/Capitalization	0.51	0.51	-1.19
Quick Ratio	0.63	0.56	-11.07
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	18.13	0.00	inf
Cash	2.52	0.00	inf
Capex	-1.06	0.00	inf
Free Cash Flow	-3.23	0.00	inf
Revenue	16.92	0.00	inf
Naive Interpretation	member

05 - Per Share Metrics · Not Interpreted

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	1.32	1.26	-4.21
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	6.94	15.38	121.75
Naive Interpretation	Member

06 - Financial Health · Weak

Rating